Johnson & Johnson Files New Trademark and Makes $14.6 B ...
Johnson & Johnson is bolstering its pharmaceutical and neurological disorder portfolios with a new trademark application for 'ICOTYDE' and a $14.6 billion acquisition of biopharmaceutical company Intra-Cellular Therapies.